A detailed history of Truvestments Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Truvestments Capital LLC holds 14,939 shares of PFE stock, worth $399,020. This represents 0.12% of its overall portfolio holdings.

Number of Shares
14,939
Previous 12,954 15.32%
Holding current value
$399,020
Previous $362,000 19.34%
% of portfolio
0.12%
Previous 0.15%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $54,984 - $62,309
1,985 Added 15.32%
14,939 $432,000
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1,465 - $1,716
-58 Reduced 0.45%
12,954 $362,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $6,550 - $7,521
-253 Reduced 1.91%
13,012 $361,000
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $13,822 - $17,954
-529 Reduced 3.84%
13,265 $381,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $288 - $337
9 Added 0.07%
13,794 $457,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $433 - $501
12 Added 0.09%
13,785 $505,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $15,125 - $19,691
-384 Reduced 2.71%
13,773 $561,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $1,127 - $1,471
27 Added 0.19%
14,157 $725,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $525 - $641
12 Added 0.08%
14,130 $618,000
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $14,470 - $17,157
311 Added 2.25%
14,118 $740,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $4,163 - $5,158
91 Added 0.66%
13,807 $715,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $32,808 - $48,632
-794 Reduced 5.47%
13,716 $810,000
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $2,472 - $3,176
63 Added 0.44%
14,510 $624,000
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $651,335 - $737,853
-18,138 Reduced 55.66%
14,447 $566,000
Q1 2021

May 18, 2021

BUY
$33.49 - $37.77 $372,643 - $420,266
11,127 Added 51.85%
32,585 $1.18 Million
Q4 2020

Feb 17, 2021

BUY
$33.47 - $42.56 $80,328 - $102,144
2,400 Added 12.59%
21,458 $790,000
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $64,420 - $75,580
-2,029 Reduced 9.62%
19,058 $699,000
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $35,119 - $42,605
1,166 Added 5.85%
21,087 $688,000
Q1 2020

May 07, 2020

SELL
$27.03 - $38.62 $338,604 - $483,792
-12,527 Reduced 38.61%
19,921 $650,000
Q4 2019

Jan 29, 2020

SELL
$32.92 - $37.36 $26,862 - $30,485
-816 Reduced 2.45%
32,448 $1.27 Million
Q3 2019

Oct 10, 2019

SELL
$32.49 - $42.13 $46,655 - $60,498
-1,436 Reduced 4.14%
33,264 $1.2 Million
Q2 2019

Jul 15, 2019

SELL
$36.98 - $41.52 $64,825 - $72,784
-1,753 Reduced 4.81%
34,700 $1.5 Million
Q1 2019

Apr 12, 2019

SELL
$37.5 - $41.2 $527,512 - $579,560
-14,067 Reduced 27.84%
36,453 $1.55 Million
Q3 2018

Oct 22, 2018

BUY
$34.47 - $41.81 $659,307 - $799,699
19,127 Added 60.93%
50,520 $2.23 Million
Q2 2018

Aug 28, 2018

BUY
$32.98 - $35.16 $1.04 Million - $1.1 Million
31,393 New
31,393 $1.14 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.